Cancer News Breast Duct Treatment For Early Breast Cancer Eliminates All Signs Of Disease In Laboratory Experiments Next Step Is To Study In Women Receiving Mastectomy Science Daily

Novel endocrine therapy giredestrant improves disease-free survival over standard of care for patients with early-stage breast cancer in phase III lidERA trial

The investigational, oral selective estrogen receptor degrader (SERD) giredestrant  given as an adjuvant therapy showed significant improvement in invasive disease-free survival (iDFS) compared with ... Read More

Adjuvant giredestrant improves invasive DFS in early breast cancer subset

Adjuvant giredestrant significantly improved invasive DFS vs. standard-of-care endocrine therapy in patients with early-stage, ER-positive, HER2-negative breast cancer.The findings were presented at ... Read More

Triple-negative breast cancer vaccine shows promise in early clinical trial

In a Phase 1 trial, women responded well to the novel vaccine. More research is needed to determine whether it can stop the cancer from recurring or possibly prevent it entirely. Read More

Sentinel lymph node biopsy may be safely omitted in some patients with early-stage breast cancer: Phase III trial

Skipping sentinel lymph node biopsy (SLNB) in patients with clinically node-negative, hormonal receptor (HR)-positive, HER2-negative early-stage breast cancer did not compromise regional control or ... Read More

Next-generation oral SERD therapy lowers the risk of breast cancer recurrence

In an international study led by UCLA, researchers have shown that giredestrant, a next-generation oral selective estrogen receptor antagonist and degrader (SERD), when given as an adjuvant therapy ... Read More

Metabolic imaging enables early response prediction in bone-dominant metastatic breast cancer

A prospective, multicenter cancer clinical trial by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) has validated an improved method for predicting treatment benefits in patients with hormone ... Read More

Cryoablation: The Minimally Invasive Freezing Technology That’s a Game-Changer for Treating Low-Risk, Early-Stage Breast Cancer

Lumpectomy has been the standard of care for low-risk, early-stage breast cancer, but now cryoablation — freezing cancer tumors to kill them — is emerging as a new option. Read More

Breast MRI may be safely omitted from diagnostic workup in certain patients with early-stage, HR-negative breast cancer

Patients with stage 1 or 2, hormone receptor (HR)-negative breast cancer had similar five-year rates of locoregional recurrence whether or not they underwent preoperative breast magnetic resonance ... Read More

Radiation may be unnecessary as an early-stage breast cancer treatment

More than half of breast cancer patients receive radiation as part of their treatment, but it may not help those with early-stage cancer, new research shows. Women who received a radiation course ... Read More

Nurse credits early detection for breast cancer treatment success

The appointment was on the books months in advance. Jaime Lamborn is a nurse, which meant she knew how important it was to schedule her first mammogram. So despite not having any symptoms of breast ... Read More

Woman’s Cancer Missed After Doctor Blamed Bra Underwire for Her Symptoms; Early Signs of Lobular Breast Cancer

Laura Mcloughlin clearly remembers the first time she saw her doctor with a breast lump and sharp pain. The medical expert told her to just stop wearing an underwire bra and trade it with a normal one ... Read More